Statins × cardiovascular events

TrialAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2005

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.

H Holdaas et al.PubMed ↗Publisher ↗

What the trial testedas reported · 1,787 people · 2005

Not counted

Reduced cardiovascular events

−29%−45% to −7%

Bigger than 7 in 10 for cardiovascular events

As reported

HR 0.71, 95% CI 0.55–0.93

One number in the abstract

the abstract, start to end

death or definite non-fatal MI (HR 0.71, 95% CI 0.55-0.93, p = 0.014).

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 0.710.55–0.93
StatinsCardiovascular events
1 / 3

81 papers cite itlatest 60 shown

2005
2007
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 16303007